2023 annual financial data

Xenetic Biosciences 2023 Net margin

Direct answer

Net margin was -162.78%.

Operating income was -4.52M USD and net income was -4.13M USD.
Operating cash flow was -4.11M USD.

Get free Xenetic Biosciences email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
2.54M USD
Operating income
-4.52M USD
Net income
-4.13M USD
Operating cash flow
-4.11M USD